Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

HABASHY, H.O., POWE, D.G., STAKA, C.M., RAKHA, E.A., BALL, G., GREEN, A.R., ALESKANDARANY, M., PAISH, E.C., MACMILLAN, R.D., NICHOLSON, R.I., ELLIS, I.O. and GEE, J.M.W., 2010. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Research and Treatment, 119 (2), pp. 283-293. ISSN 0167-6806

Full text not available from this repository.
Item Type: Journal article
Publication Title: Breast Cancer Research and Treatment
Creators: Habashy, H.O., Powe, D.G., Staka, C.M., Rakha, E.A., Ball, G., Green, A.R., Aleskandarany, M., Paish, E.C., Macmillan, R.D., Nicholson, R.I., Ellis, I.O. and Gee, J.M.W.
Date: 2010
Volume: 119
Number: 2
ISSN: 0167-6806
Identifiers:
NumberType
10.1007/s10549-009-0345-xDOI
Divisions: Schools > School of Science and Technology
Depositing User: EPrints Services
Date Added: 09 Oct 2015 10:26
Last Modified: 09 Jun 2017 13:30
URI: http://irep.ntu.ac.uk/id/eprint/13003

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year